Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine in subjects at risk for Alzheimer's disease
NCT00933608Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jul 2009
- Primary completion
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by NYU Langone Health. Started Jul 2009; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00933608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00933608.